Cannabis antagonists: a new era of social psychopharmacology?

Abstract

Get full access to this article

View all access options for this article.

References

Anthenelli R , Despres J-P (2004) Rimonabant In Obesity (RIO-Lipids) study: presented at a late-breaking clinical trials session at the 53rd Annual Scientific Session of the American College of Cardiology. http://en.sanofi-synthelabo.com/press/p_press.asp

Arseneault L , Cannon M , Witton J , Murray R M (2004) Causal association between cannabis and psychosis: examination of the evidence . Br J Psychiatry 184: 110-117

Dettmer K , Saunders B , Strang J (2001) Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes . BMJ 322: 895-896

Home Office Report on Cannabis (2002) http://www.drugs.gov.uk/ReportsandPublications/Communities/1034155489/Classific_Cannabis_MisuseDrugsAct1971.pdf

Nutt D J , Nash J (2002) Cannabis - an update. Home Office publications. http://www.drugs.gov.uk/ReportsandPublications/Communities/1034165905/Cannabis_update_1999to2002.pdf

Verdoux H , Tournier M (2004) Cannabis use and risk of psychosis: an etiological link? Epidemiol Psichiatr Soc 13: 113-119